In a large cohort of MM patients, Paiva et al. showed that MRD by NGF has a high applicability (99%) and a high prediction accuracy of both PFS and OS: only 7% of MRD-negative patients (sensitivity 10−6) relapsed, most of them with extramedullary disease. Here, NGF is linked to Miyoshi myopathy.